Stocktoria
Synergy CHC Corp. SNYR
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2013-11-08
Synergy CHC Corp. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $30.4M | $34.8M | $42.8M | $29.4M | $33.8M |
| Gross profit | $20.3M | $23.6M | $32.1M | $20.2M | $22.8M |
| Operating income | -$8.5M | $5.8M | $10.8M | -$8.0M | -$4.9M |
| Interest expense | — | $1.5M | $1.7M | — | $1.1M |
| Income tax | $117,471 | $102,085 | $234,980 | -$131,537 | $247,694 |
| Net income | -$12.3M | $2.1M | $6.3M | -$9.2M | -$6.2M |
| EPS (diluted) | $-1.27 | $0.28 | $0.86 | $-0.10 | $-0.07 |
| Operating cash flow | -$2.6M | -$4.8M | $421,729 | $2.9M | $1.3M |
| Free cash flow | — | — | — | — | $1.2M |
| Cash & equivalents | $2.6M | $687,920 | $632,534 | $1.2M | $459,736 |
| Inventory | $3.7M | $1.7M | $3.7M | $1.9M | $2.7M |
| Total assets | $10.2M | $16.3M | $12.2M | $5.2M | $20.0M |
| Total liabilities | $33.3M | $33.0M | $39.5M | $10.4M | $16.0M |
| Shareholders' equity | -$23.1M | -$16.6M | -$27.3M | -$5.2M | $4.0M |
Source: SEC EDGAR filings · CIK 0001562733 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.